Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

After matching (n = 4,343 per group), patients with pre-stroke VDD demonstrated significantly higher 30-day AKI incidence compared with those with sufficient vitamin D levels (5.3% vs. 3.5%; odds ratio [OR] = 1.55, 95% confidence interval [CI] 1.26 to 1.92; p < 0.001).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D deficiency and risk of acute kidney injury after ischemic stroke: a propensity-matched cohort study

Source: Article title.

Patients were stratified based on serum 25-hydroxyvitamin D levels measured within 6 weeks pre-stroke: VDD group (<20 ng/mL) and control group (≥30 ng/mL).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D deficiency and risk of acute kidney injury after ischemic stroke: a propensity-matched cohort study

Cohort study · Frontiers in Nutrition · 2026

Original publication title

Vitamin D deficiency and risk of acute kidney injury after ischemic stroke: a propensity-matched cohort study

Kuo-Chuan Hung; Li-Chen Chang; Yi-Chen Lai; Ming Yew; Ping-Hsin Liu; I-Wen Chen

Copyright © 2026 Hung, Chang, Lai, Yew, Liu and Chen.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Pre-stroke VDD is associated with increased risk of post-stroke AKI and other adverse outcomes. The observed dose-dependent relationship suggests potential benefits from optimizing vitamin D status. These findings highlight the importance of assessing vitamin D levels in stroke risk stratification and suggest potential preventive strategies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D deficiency (VDD) has been linked to adverse outcomes in various clinical settings, but its relationship with post-stroke acute kidney injury (AKI) remains unexplored.

Source: Background

Abstract: What methods does the paper describe?

This retrospective cohort study utilized the TriNetX research network database to identify adult patients with first-documented ischemic stroke between January 2010 and December 2024. Patients were stratified based on serum 25-hydroxyvitamin D levels measured within 6 weeks pre-stroke: VDD group (<20 ng/mL) and control group (≥30 ng/mL). After 1:1 propensity score matching, we compared 30-day and 1 to 12 month outcomes between groups, with the primary outcome being AKI incidence within 30 days post-stroke.

Source: Methods

Abstract: Results

After matching (n = 4,343 per group), patients with pre-stroke VDD demonstrated significantly higher 30-day AKI incidence compared with those with sufficient vitamin D levels (5.3% vs. 3.5%; odds ratio [OR] = 1.55, 95% confidence interval [CI] 1.26 to 1.92; p < 0.001). VDD was also associated with increased risks of all-cause mortality (OR = 1.63, 95% CI 1.26 to 2.12), intensive care unit (ICU) admission (OR = 1.55, 95% CI 1.30 to 1.84), pneumonia (OR = 1.48, 95% CI 1.09 to 2.02), and dialysis requirement (OR = 2.33, 95% CI 1.36 to 4.00).

Vitamin D insufficiency (20 to 29 ng/mL) was associated with a milder but significant AKI risk increase (OR = 1.39, 95% CI 1.12 to 1.72; p = 0.003). The adverse effect of VDD persisted during 1 to 12 month follow-up, with higher risks of AKI (hazard ratio [HR] = 1.32, 95% CI 1.13 to 1.55) and progression to end-stage renal disease (HR = 1.69, 95% CI 1.16 to 2.46).

Source: Results

Abstract: Conclusion

Pre-stroke VDD is associated with increased risk of post-stroke AKI and other adverse outcomes. The observed dose-dependent relationship suggests potential benefits from optimizing vitamin D status. These findings highlight the importance of assessing vitamin D levels in stroke risk stratification and suggest potential preventive strategies.

Source: Conclusion
Authors’ abstract

Background

Vitamin D deficiency (VDD) has been linked to adverse outcomes in various clinical settings, but its relationship with post-stroke acute kidney injury (AKI) remains unexplored.

Methods

This retrospective cohort study utilized the TriNetX research network database to identify adult patients with first-documented ischemic stroke between January 2010 and December 2024. Patients were stratified based on serum 25-hydroxyvitamin D levels measured within 6 weeks pre-stroke: VDD group (<20 ng/mL) and control group (≥30 ng/mL). After 1:1 propensity score matching, we compared 30-day and 1 to 12 month outcomes between groups, with the primary outcome being AKI incidence within 30 days post-stroke.

Results

After matching (n = 4,343 per group), patients with pre-stroke VDD demonstrated significantly higher 30-day AKI incidence compared with those with sufficient vitamin D levels (5.3% vs. 3.5%; odds ratio [OR] = 1.55, 95% confidence interval [CI] 1.26 to 1.92; p < 0.001). VDD was also associated with increased risks of all-cause mortality (OR = 1.63, 95% CI 1.26 to 2.12), intensive care unit (ICU) admission (OR = 1.55, 95% CI 1.30 to 1.84), pneumonia (OR = 1.48, 95% CI 1.09 to 2.02), and dialysis requirement (OR = 2.33, 95% CI 1.36 to 4.00).

Vitamin D insufficiency (20 to 29 ng/mL) was associated with a milder but significant AKI risk increase (OR = 1.39, 95% CI 1.12 to 1.72; p = 0.003). The adverse effect of VDD persisted during 1 to 12 month follow-up, with higher risks of AKI (hazard ratio [HR] = 1.32, 95% CI 1.13 to 1.55) and progression to end-stage renal disease (HR = 1.69, 95% CI 1.16 to 2.46).

Conclusion

Pre-stroke VDD is associated with increased risk of post-stroke AKI and other adverse outcomes. The observed dose-dependent relationship suggests potential benefits from optimizing vitamin D status. These findings highlight the importance of assessing vitamin D levels in stroke risk stratification and suggest potential preventive strategies.

Publication and source details

Original title: Vitamin D deficiency and risk of acute kidney injury after ischemic stroke: a propensity-matched cohort study

Kuo-Chuan Hung; Li-Chen Chang; Yi-Chen Lai; Ming Yew; Ping-Hsin Liu; I-Wen Chen

Frontiers in Nutrition · 2026

* Correspondence: I-Wen Chen, cheniwena60912@gmail.comCopyright © 2026 Hung, Chang, Lai, Yew, Liu and Chen.2026Hung, Chang, Lai, Yew, Liu and Chenhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare that no financial support was received for the research and/or publication of this article.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:26:08.968275+00:00

DOI: 10.3389/fnut.2025.1709491 · PMC12812757